Diamantidis Dimitrios, Lailisidis Stavros, Panagiotopoulos Nikolaos, Giannopoulos Stavros, Georgellis Chrysostomos, Tsakaldimis Georgios, Kalaitzis Christos, Giannakopoulos Stilianos
Department of Urology, Democritus University of Thrace, Alexandroupolis, Greece.
Endoscopic Unit, Democritus University of Thrace, Alexandroupolis, Greece.
BMC Urol. 2025 Mar 27;25(1):58. doi: 10.1186/s12894-025-01746-2.
To describe and analyze our experience with secondary (redo) laparoscopic pyeloplasty (rLP) in managing recurrent ureteropelvic junction obstruction (UPJO) following primary pyeloplasty, and to compare our outcomes with those reported in the existing literature.
A retrospective analysis was conducted on patients who underwent rLP for recurrent UPJO. Baseline characteristics, detailed histories of previous pyeloplasties, operative profiles, and follow-up data were collected and analyzed. Furthermore, a comprehensive literature review was performed using PubMed.
The study included eight patients (four men, four women) with a mean age of 27 years who underwent rLP. Among them, three had left-side and five had right-side involvement. Three patients had undergone open pyeloplasty, three laparoscopic pyeloplasty, one robot-assisted pyeloplasty, and one laparoscopic pyeloplasty and failed salvage endopyelotomy. Recurrent UPJO etiologies were recurrent stenosis (five cases), fibrosis and adhesions (two cases), and a combination of fibrosis, adhesions, and high insertion (one case). No crossing vessels were involved. Seven patients were treated using the dismembered technique, and one with Y-V plasty. The mean operation time was 185 min (range 150-240), and all procedures were completed laparoscopically. No blood transfusions were required intra- or postoperatively. The mean hospital stay was 2.8 days (range 2-4). Two patients (25%) experienced postoperative complications (one Clavien grade II and one Clavien grade IIIa). The mean follow-up period was 39 months (range 18-78), with a success rate of 87.5%.
This study contributes additional evidence that rLP is an effective and reliable treatment for secondary UPJO, achieving high success rates despite its technical challenges.
描述并分析我们在处理初次肾盂成形术后复发性输尿管肾盂连接部梗阻(UPJO)时进行二次(再次)腹腔镜肾盂成形术(rLP)的经验,并将我们的结果与现有文献报道的结果进行比较。
对因复发性UPJO接受rLP的患者进行回顾性分析。收集并分析患者的基线特征、既往肾盂成形术的详细病史、手术情况及随访数据。此外,使用PubMed进行全面的文献综述。
该研究纳入8例接受rLP的患者(4例男性,4例女性),平均年龄27岁。其中,3例为左侧受累,5例为右侧受累。3例患者曾接受开放肾盂成形术,3例接受腹腔镜肾盂成形术,1例接受机器人辅助肾盂成形术,1例接受腹腔镜肾盂成形术且挽救性肾盂内切开术失败。复发性UPJO的病因包括复发性狭窄(5例)、纤维化和粘连(2例)以及纤维化、粘连和高位插入的组合(1例)。无交叉血管受累。7例患者采用离断技术治疗,1例采用Y-V成形术。平均手术时间为185分钟(范围150 - 240分钟),所有手术均通过腹腔镜完成。术中及术后均无需输血。平均住院时间为2.8天(范围2 - 4天)。2例患者(25%)出现术后并发症(1例Clavien II级,1例Clavien IIIa级)。平均随访期为39个月(范围18 - 78个月),成功率为87.5%。
本研究提供了更多证据表明rLP是治疗继发性UPJO的一种有效且可靠的方法,尽管存在技术挑战,但仍能取得较高的成功率。